TAKING AIM
AT THE CAUSE OF
GENETIC DISEASES
Advancing science with curative potential for both cardiovascular and APOE4 associated Alzheimer’s disease areas
Our approach
Our strategy centers on high-impact genetic medicine candidates for cardiovascular diseases and APOE4-associated Alzheimer’s disease, prioritizing efficient development, advanced manufacturing, and strategic partnerships.
Our Team
Building on groundbreaking research from Weill Cornell Medicine and the University of California San Diego, we partner with preeminent institutions on the cutting edge of gene therapy research.
